Business Description
Ningbo Scientz Biotechnology Co Ltd
ISIN : CNE100005LK0
Total Employee Number:
349Compare
Compare
Traded in other countries / regions
920685.China IPO Date
2022-10-10Description
Ningbo Scientz Biotechnology Co Ltd is involved in the Research and Development, production and sales of life science instruments.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 41.78 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.16 | |||||
Interest Coverage | 243.03 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 10.45 | |||||
Beneish M-Score | -2.52 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.6 | |||||
3-Year EBITDA Growth Rate | -8.5 | |||||
3-Year EPS without NRI Growth Rate | -8.3 | |||||
3-Year FCF Growth Rate | -23.3 | |||||
3-Year Book Growth Rate | 0.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.87 | |||||
9-Day RSI | 49.51 | |||||
14-Day RSI | 52.86 | |||||
3-1 Month Momentum % | -18.03 | |||||
6-1 Month Momentum % | -26.93 | |||||
12-1 Month Momentum % | -37.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.98 | |||||
Quick Ratio | 5.1 | |||||
Cash Ratio | 4.8 | |||||
Days Inventory | 285.65 | |||||
Days Sales Outstanding | 19.89 | |||||
Days Payable | 194.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.07 | |||||
Dividend Payout Ratio | 0.43 | |||||
Forward Dividend Yield % | 1.07 | |||||
5-Year Yield-on-Cost % | 1.07 | |||||
Shareholder Yield % | 0.76 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 63.1 | |||||
Operating Margin % | 27.7 | |||||
Net Margin % | 20.74 | |||||
EBITDA Margin % | 28.35 | |||||
FCF Margin % | 14.94 | |||||
OCF Margin % | 31.19 | |||||
ROE % | 6.49 | |||||
ROA % | 5.45 | |||||
ROIC % | 15.8 | |||||
3-Year ROIIC % | -5.6 | |||||
ROC (Joel Greenblatt) % | 26.93 | |||||
ROCE % | 8.29 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.71 | |||||
Forward PE Ratio | 14.85 | |||||
PE Ratio without NRI | 29.28 | |||||
Shiller PE Ratio | 24.71 | |||||
Price-to-Owner-Earnings | 179.12 | |||||
PS Ratio | 6.09 | |||||
PB Ratio | 1.97 | |||||
Price-to-Tangible-Book | 2.07 | |||||
Price-to-Free-Cash-Flow | 38.79 | |||||
Price-to-Operating-Cash-Flow | 19.06 | |||||
EV-to-EBIT | 16.85 | |||||
EV-to-EBITDA | 16.85 | |||||
EV-to-Revenue | 4.78 | |||||
EV-to-FCF | 31.96 | |||||
Price-to-GF-Value | 0.76 | |||||
Price-to-Projected-FCF | 1.76 | |||||
Price-to-Graham-Number | 1.64 | |||||
| Price-to-Net-Current-Asset-Value | 3.61 | |||||
| Price-to-Net-Cash | 4.89 | |||||
Earnings Yield (Greenblatt) % | 5.93 | |||||
FCF Yield % | 2.3 | |||||
Forward Rate of Return (Yacktman) % | 6.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ningbo Scientz Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 171.955 | ||
| EPS (TTM) (Â¥) | 0.41 | ||
| Beta | 1.0295 | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.45 | ||
| Volatility % | 43.48 | ||
| 14-Day RSI | 52.86 | ||
| 14-Day ATR (Â¥) | 0.620893 | ||
| 20-Day SMA (Â¥) | 11.9995 | ||
| 12-1 Month Momentum % | -37.57 | ||
| 52-Week Range (Â¥) | 9.76 - 20.99 | ||
| Shares Outstanding (Mil) | 91.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ningbo Scientz Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ningbo Scientz Biotechnology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.130000 Cash Dividend | 2026-06-09 | 11.82 (+2.96%) | ||
| CNY 0.180000 Cash Dividend | 2025-05-29 | 14.82 (-3.33%) |
Show
Entries
Ningbo Scientz Biotechnology Co Ltd Frequently Asked Questions
What is Ningbo Scientz Biotechnology Co Ltd(BJSE:920685)'s stock price today?
The current price of BJSE:920685 is ¥12.18. The 52 week high of BJSE:920685 is ¥20.99 and 52 week low is ¥9.76.
When is next earnings date of Ningbo Scientz Biotechnology Co Ltd(BJSE:920685)?
The next earnings date of Ningbo Scientz Biotechnology Co Ltd(BJSE:920685) is .
Does Ningbo Scientz Biotechnology Co Ltd(BJSE:920685) pay dividends? If so, how much?
The Dividend Yield %  of Ningbo Scientz Biotechnology Co Ltd(BJSE:920685) is 1.07% (As of Today), Highest Dividend Payout Ratio of Ningbo Scientz Biotechnology Co Ltd(BJSE:920685) was 1.23. The lowest was 0.43. And the median was 0.95. The  Forward Dividend Yield % of Ningbo Scientz Biotechnology Co Ltd(BJSE:920685) is 1.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ningbo Scientz Biotechnology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers